Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de36eaaa471d491a1c3f2ae25eaef97 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate |
1985-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa862104c054b8db92fc3936077d677 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef400596ad2920efabac2a0cfcc0dda |
publicationDate |
1986-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0170937-A1 |
titleOfInvention |
Double salt of desoxyfructosyl-serotonine and of creatinine, its preparation and medicaments containing it |
abstract |
The double sulfate of 1-deoxy- (5-hydroxy-tryptamino) -D-fructose (DFS) and 1-methyl-hydantoin-2-imide (creatinine) constitutes a new crystallized solid phase of unitary composition, of pharmaceutical quality and remarkable stability.n n n It is prepared by glycosylation of serotonin with D-glucose, formation of the double salt by addition of sulfuric acid and creatinine and crystallization of the latter in the presence of ethanol.n n n Preferably, the DFS is isolated from the reaction medium via the DFS ยท Ca (OH) 2 addition complex, precipitated by the addition of calcium hydroxide. The calcium hydroxide is then removed by adding sulfuric acid and the double salt crystallized as above.n n n DFS is the active ingredient in an effective medication, especially for the treatment of leprosy. |
priorityDate |
1984-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |